Prior authorization required for Xenpozyme

CarePartners of Connecticut now requires prior authorization for coverage of Xenpozyme (HCPCS code J3490), an enzyme replacement therapy approved by the FDA in August 2022.

For complete information, please refer to the newly developed Xenpozyme Medical Necessity Guidelines, which outline the criteria that must be met for initial authorization and renewal, approved indications, coverage limitations, and more.